Month: March 2022

AstraZeneca (AZN) has incremental revenue visibility from the antibody cocktail against covid-19 Pfizer (PFE) has a robust backlog of vaccine doses. Additional booster shot to provide revenue upside. Moderna (MRNA) continues to increase its backlog for 2022. Potential catalyst is vaccine for kids under six. Source: shutterstock.com/PhotobyTawat Covid-19 and its variants have been as unpredictable
0 Comments
Without a doubt, the outlook of Clover Health (NASDAQ:CLOV) stock has improved tremendously since I last wrote about the company in a September 2021 column. Source: Dennis Diatel / Shutterstock.com Most importantly, CLOV stock has tumbled a great deal since September, making its valuation much less daunting. But the insurer’s fourth-quarter results and 2022 guidance
0 Comments
The money you contribute to your pension doesn’t necessarily have to be invested in just stocks, bonds, and active and passive funds. If you’re feeling especially brave, you can consider opening a self-directed Roth IRA. These retirement accounts permit you to stake your future on more exotic asset classes, including precious metals, real estate, cryptocurrency,
0 Comments